Several major organizations, including the Global Fund and PEPFAR, have unveiled a plan to rapidly provide affordable access to lenacapavir, a potentially groundbreaking HIV prevention drug, in lower-income countries. The drug, already approved in some countries for treating multidrug-resistant HIV, showed 100% effectiveness in preventing infection in early trials. The goal is to secure sustainable access for at least two million people over three years.
GENEVA, Switzerland — Several giant US and international groups focused on fighting HIV and AIDS on Tuesday unveiled a plan to swiftly provide affordable access to a possibly 'game-changing' HIV prevention drug in lower-income countries.
The Global Fund said the aim now was 'to secure sustainable arrangements for countries to access this new, potentially game-changing HIV prevention innovation,' enabling 'access to lenacapavir for at least two million people over three years.'The plan, also backed by the World Health Organization, the Children's Investment Fund Foundation and the Bill & Melinda Gates Foundation, depends on regulatory approvals and a recommendation from the WHO, it said.
HIV AIDS Lenacapavir Global Fund PEPFAR Public Health
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Do condoms protect us from HIV? Doctor answersLatest Philippine news from GMA News and 24 Oras. News, weather updates and livestreaming on Philippine politics, regions, showbiz, lifestyle, science and tech.
Read more »
UN Reports Fewest New HIV Cases Since Disease Emerged, But Progress Too SlowThe United Nations reported Tuesday that fewer people contracted HIV in 2023 than at any point since the disease's rise in the late 1980s, but the decline is still considered too slow. While significant strides have been made, challenges remain.
Read more »
World's First HIV Vaccine Shows 100% Effectiveness in Women, Near 100% in MenA groundbreaking vaccine against HIV, administered twice yearly, has shown 100 percent effectiveness in preventing HIV infections in women and near 100 percent in men, according to a study published on November 27, 2024. Drugmaker Gilead plans to make generic versions available in 120 poor countries but has excluded most of Latin America, raising concerns about missed opportunities to control the disease.
Read more »
DOH-13 Records 185 New HIV Cases, Total Reaches 1,718 in Caraga RegionThe Department of Health-Caraga (DOH-13) has reported 185 new HIV cases, bringing the total number to 1,718. Agusan del Sur leads with the most cases, followed by Surigao del Sur and Surigao del Norte. DOH-13 emphasizes the importance of early diagnosis and has established nine HIV treatment hubs across the region.
Read more »
UNICEF Raises Alarm on High HIV Infection Rate Among Young Women and GirlsThe UN's children's fund raised alarm over the high rate of new HIV infections among young women and girls, highlighting their lack of access to prevention and treatment. The report, ahead of World AIDS Day, revealed that 7 out of 10 new adolescent infections are among girls, with sub-Saharan Africa seeing nine out of 10 new infections among girls aged 15-19.
Read more »
World AIDS Day: HIV Cases and AIDS-Related Deaths Rising in Western Pacific RegionAhead of World AIDS Day, the World Health Organization (WHO) reported a surge in HIV cases and AIDS-related deaths in the Western Pacific region since 2019, reversing years of progress. New infections climbed by 8% and deaths increased by 10%, with 16 new infections and six HIV-related deaths occurring hourly. The Philippines mirrors this trend, with 5,321 new HIV cases recorded in the second quarter of this year.
Read more »